201 related articles for article (PubMed ID: 23017088)
1. Thromboelastography in patients with acute ischemic stroke.
Elliott A; Wetzel J; Roper T; Pivalizza E; McCarthy J; Wallace C; Hess MJ; Peng H; Rahbar MH; Sangha N; Grotta JC
Int J Stroke; 2015 Feb; 10(2):194-201. PubMed ID: 23017088
[TBL] [Abstract][Full Text] [Related]
2. Iodinated contrast does not alter clotting dynamics in acute ischemic stroke as measured by thromboelastography.
McDonald MM; Archeval-Lao JM; Cai C; Peng H; Sangha N; Parker SA; Wetzel J; Riney SA; Cherches MF; Guthrie GJ; Roper TC; Kawano-Castillo JF; Pandurengan R; Rahbar MH; Grotta JC
Stroke; 2014 Feb; 45(2):462-6. PubMed ID: 24370757
[TBL] [Abstract][Full Text] [Related]
3. Thromboelastographic changes in patients experiencing an acute ischemic stroke and receiving alteplase.
Rowe AS; Greene CL; Snider CC; Carroll RC; Wiseman BF; Henry JM; Langdon JR; Craft RM
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1307-11. PubMed ID: 24439128
[TBL] [Abstract][Full Text] [Related]
4. Thrombelastography does not predict clinical response to rtPA for acute ischemic stroke.
McDonald MM; Wetzel J; Fraser S; Elliott A; Bowry R; Kawano-Castillo JF; Cai C; Sangha N; Messier J; Hassler A; Archeval-Lao J; Parker SA; Rahbar MH; Pivalizza EG; Chang TR; Grotta JC
J Thromb Thrombolysis; 2016 Apr; 41(3):505-10. PubMed ID: 26407682
[TBL] [Abstract][Full Text] [Related]
5. "Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke.
Bliden KP; Raviv G; Tantry US; Chaudhary R; Cochran JW; Navarese EP; Brannan T; Vyas A; Gurbel PA
J Thromb Thrombolysis; 2019 Feb; 47(2):192-199. PubMed ID: 30673942
[TBL] [Abstract][Full Text] [Related]
6. Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome.
Bembenek JP; Niewada M; Siudut J; Plens K; Członkowska A; Undas A
Thromb Haemost; 2017 Jun; 117(7):1440-1447. PubMed ID: 28382369
[TBL] [Abstract][Full Text] [Related]
7. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
8. In acute ischemic stroke patients with smoking incidence, are more women than men more likely to be included or excluded from thrombolysis therapy?
Rotimi OR; Ajani IF; Penwell A; Lari S; Walker B; Nathaniel TI
Womens Health (Lond); 2020; 16():1745506520922760. PubMed ID: 32459136
[TBL] [Abstract][Full Text] [Related]
9. Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.
Kim SH; Saver JL
Stroke; 2015 Jan; 46(1):132-6. PubMed ID: 25424482
[TBL] [Abstract][Full Text] [Related]
10. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
11. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
[TBL] [Abstract][Full Text] [Related]
12. Factor seven activating protease (FSAP) predicts response to intravenous thrombolysis in acute ischemic stroke.
Bustamante A; Díaz-Fernández B; Giralt D; Boned S; Pagola J; Molina CA; García-Berrocoso T; Kanse SM; Montaner J
Int J Stroke; 2016 Aug; 11(6):646-55. PubMed ID: 27073188
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Thromboelastography in the Detection and Management of Tissue Plasminogen Activator-Associated Hyperfibrinolysis.
Rosafio F; Vandelli L; Bigliardi G; Cavallieri F; Dell'Acqua ML; Picchetto L; Zini A
J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):e29-e31. PubMed ID: 27889194
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke.
Majidi S; Simpkins AN; Leigh R;
J Neuroimaging; 2019 Mar; 29(2):206-210. PubMed ID: 30508260
[TBL] [Abstract][Full Text] [Related]
15. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
[TBL] [Abstract][Full Text] [Related]
17. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
Rusanen H; Saarinen JT; Sillanpää N
Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
[TBL] [Abstract][Full Text] [Related]
18. Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials.
Lorenz MW; Lauer A; Foerch C
Stroke; 2015 Nov; 46(11):3168-76. PubMed ID: 26443833
[TBL] [Abstract][Full Text] [Related]
19. Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke.
Adams RJ; Cox M; Ozark SD; Kanter J; Schulte PJ; Xian Y; Fonarow GC; Smith EE; Schwamm LH
Stroke; 2017 Mar; 48(3):686-691. PubMed ID: 28183857
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activation and thrombolysis for ischemic stroke.
Medcalf RL; Davis SM
Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
